144 related articles for article (PubMed ID: 9215151)
1. The hormonal receptor status of uterine carcinosarcomas (mixed müllerian tumours): an immunohistochemical study.
Ansink AC; Cross PA; Scorer P; de Barros Lopes A; Monaghan JM
J Clin Pathol; 1997 Apr; 50(4):328-31. PubMed ID: 9215151
[TBL] [Abstract][Full Text] [Related]
2. Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component.
de Jong RA; Nijman HW; Wijbrandi TF; Reyners AK; Boezen HM; Hollema H
Mod Pathol; 2011 Oct; 24(10):1368-79. PubMed ID: 21572397
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma (malignant mixed müllerian [mesodermal] tumor) of the uterus and ovary. Correlation of clinical, pathologic, and immunohistochemical features in 29 cases.
Costa MJ; Khan R; Judd R
Arch Pathol Lab Med; 1991 Jun; 115(6):583-90. PubMed ID: 1710102
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.
Amant F; Schurmans K; Steenkiste E; Verbist L; Abeler VM; Tulunay G; De Jonge E; Massuger L; Moerman P; Vergote I
Gynecol Oncol; 2004 Jun; 93(3):680-5. PubMed ID: 15196864
[TBL] [Abstract][Full Text] [Related]
5. Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma.
Huang GS; Arend RC; Li M; Gunter MJ; Chiu LG; Horwitz SB; Goldberg GL
Am J Obstet Gynecol; 2009 Apr; 200(4):457.e1-5. PubMed ID: 19200930
[TBL] [Abstract][Full Text] [Related]
6. p53 immunostaining suggests that uterine carcinosarcomas are monoclonal.
Mayall F; Rutty K; Campbell F; Goddard H
Histopathology; 1994 Mar; 24(3):211-4. PubMed ID: 8200622
[TBL] [Abstract][Full Text] [Related]
7. Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets.
Cimbaluk D; Rotmensch J; Scudiere J; Gown A; Bitterman P
Gynecol Oncol; 2007 Apr; 105(1):138-44. PubMed ID: 17175012
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of carcinomatous and sarcomatous components in the uterine carcinosarcoma: a case report.
Semczuk A; Skomra D; Chyzyńska M; Szewczuk W; Olcha P; Korobowicz E
Pathol Res Pract; 2008; 204(3):203-7. PubMed ID: 18207653
[TBL] [Abstract][Full Text] [Related]
9. Nestin: A biomarker of aggressive uterine cancers.
Hope ER; Mhawech-Fauceglia P; Pejovic T; Zahn CM; Wang G; Conrads TP; Larry Maxwell G; Hamilton CA; Darcy KM; Syed V
Gynecol Oncol; 2016 Mar; 140(3):503-11. PubMed ID: 26718725
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients.
Iwasa Y; Haga H; Konishi I; Kobashi Y; Higuchi K; Katsuyama E; Minamiguchi S; Yamabe H
Cancer; 1998 Feb; 82(3):512-9. PubMed ID: 9452269
[TBL] [Abstract][Full Text] [Related]
11. Pathology of mixed Müllerian tumours.
D'Angelo E; Prat J
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):705-18. PubMed ID: 21742560
[TBL] [Abstract][Full Text] [Related]
12. Oestrogen, progesterone, and androgen receptors in ovarian neoplasia: correlation between immunohistochemical and biochemical receptor analyses.
van Doorn HC; Burger CW; van der Valk P; Bonfrèr HM
J Clin Pathol; 2000 Mar; 53(3):201-5. PubMed ID: 10823139
[TBL] [Abstract][Full Text] [Related]
13. Unusual Cutaneous Metastasis of Uterine Carcinosarcoma: A Case Report and Review of the Literature.
Clairwood M; Yasuda M; Belazarian L; Deng A
Am J Dermatopathol; 2016 May; 38(5):366-9. PubMed ID: 26675357
[TBL] [Abstract][Full Text] [Related]
14. Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics.
Chen X; Arend R; Hamele-Bena D; Tergas AI; Hawver M; Tong GX; Wright TC; Wright JD
Int J Gynecol Pathol; 2017 Sep; 36(5):412-419. PubMed ID: 28700424
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case series.
Leath CA; Straughn JM; Conner MG; Barnes MN; Alvarez RD; Partridge EE; Huh WK
J Reprod Med; 2004 Feb; 49(2):71-5. PubMed ID: 15018431
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of matrix metalloprotease-7 in each component of uterine carcinosarcoma.
Tanimoto H; Shigemasa K; Sasaki M; Katayama H; Kusumi I; Parmley TH; O'Brien TJ; Ohama K
Oncol Rep; 2000; 7(6):1209-12. PubMed ID: 11032915
[TBL] [Abstract][Full Text] [Related]
17. Carcinosarcoma (malignant mixed müllerian tumor) of the uterus with a rhabdoid tumor component. An immunohistochemical, ultrastructural, and immunoelectron microscopic case study.
Mount SL; Lee KR; Taatjes DJ
Am J Clin Pathol; 1995 Feb; 103(2):235-9. PubMed ID: 7856569
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical localization of oestrogen and progesterone receptors in primary adenocarcinoma of the cervix.
Ghandour FA; Attanoos R; Nahar K; Gee JW; Bigrigg A; Ismail SM
Histopathology; 1994 Jan; 24(1):49-55. PubMed ID: 8144142
[TBL] [Abstract][Full Text] [Related]
19. Carcinosarcoma of the uterus in advanced stage: a case report.
Tasic L; Vasiljevic M; Prorocic M; Jurisic A; Dragojevic-Dikic S; Jankovic-Raznatovic S
Eur J Gynaecol Oncol; 2013; 34(4):343-6. PubMed ID: 24020144
[TBL] [Abstract][Full Text] [Related]
20. [Research on the relationship between estrogen receptor, progesterone receptor, cell proliferation associated antigen in uterine leiomyoma and nuclear body density of myoma, serum reproductive hormone concentrations].
Wu J; Cheng Y
Zhonghua Fu Chan Ke Za Zhi; 1995 Oct; 30(10):603-7. PubMed ID: 8745507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
